Navigation Links
FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body
Date:10/14/2011

SILVER SPRING, Md., Oct. 14, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Ferriprox (deferiprone) to treat patients with iron overload due to blood transfusions in patients with thalassemia, a genetic blood disorder that causes anemia, who had an inadequate response to prior chelation therapy.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Patients with thalassemia have excess iron in the body from the frequent blood transfusions (transfusional iron overload), a condition that is serious and can be fatal.  These patients also have a risk of developing liver disease, diabetes, arthritis, heart failure or an abnormal heart rhythm.  

The standard of care to treat transfusional iron overload is chelation therapy – chemical agents that are used to remove heavy metals from the body. Ferriprox is intended for use when chelation therapy is inadequate.

"Ferriprox represents the first new FDA-approved treatment for this disorder since 2005," said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research.

The safety and effectiveness of Ferriprox is based on an analysis of data from twelve clinical studies in 236 patients. Patients participating in the study did not respond to prior iron chelation therapy.  Ferriprox was considered a successful treatment for patients who experienced at least a 20 percent decrease in serum ferritin, a protein that stores iron in the body for later use. Half of the patients in the study experienced at least a 20 percent decrease in ferritin levels.

The most common side effects seen in patients who received Ferriprox included nausea, vomiting, abdominal and joint pain, urine discoloration (chromaturia), a decrease in the number of white blood cells (neutropenia), and an increase in
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... (Nasdaq: LMNX ) today announced that it expects ... Monday, February 3, 2014. A press release announcing the results ... (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) Management will ... financial results for the fourth quarter and twelve months ended ...
(Date:1/14/2014)... Pa. , Jan. 14, 2014 Dynamic Healthcare Services, ... announced today that it acquired Progressive Home Medical Equipment, Inc. ... 7, 2014. The terms of the acquisition were not disclosed. ... equipment ("DME") company providing a wide range of sleep, mobility, ...
(Date:1/14/2014)... NuAire , a manufacturer of ergonomically designed laboratory equipment ... of Japan to sell and service the ... NuAire will utilize its network of sales professionals throughout ... to offer assistance in application use, product benefits and features, options ...
Breaking Medicine Technology:Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3NuAire announces sales and service of Hitachi Koki centrifuges in North America 2
... A recent article in Arizona ,s Gilbert Examiner ... the launch of " PPA 2.0 ," the organization,s online expansion of the program. ... PPA has helped more than 6.5 ... provide free or nearly free medications. "This achievement in Arizona is especially ...
... Working with an internal whistleblower, Attorney Warner Mendenhall , the ... Alex Rokakis and Michelle Heyer have worked for four years ... , , , ... investigation, St. Jude has agreed to return $3,898,300 to the federal ...
Cached Medicine Technology:Arizona Residents Get Help With Medicines Through PPA 2.0 2Arizona Residents Get Help With Medicines Through PPA 2.0 3St. Jude Medical and Hospitals in Ohio and Kentucky to Pay Almost $4 Million to Federal Government to Resolve Fraud Allegations 2
(Date:4/22/2014)... may throw tantrums like toddlers, but their total ... say, a gerbil or fox squirrel, according to ... and birds ranging from orangutans to zebra finches. ... Yale and more than two-dozen other research institutions ... evolution of self-control, defined in the study as ...
(Date:4/22/2014)... LOS ANGELES (April 22, 2014) Cedars-Sinai stroke intervention ... Neurological Disorders and Stroke, part of the National Institutes ... fund a multicenter Phase II clinical trial of an ... will be used in combination with recombinant tissue plasminogen ... to treat ischemic strokes shortly after onset. In laboratory ...
(Date:4/22/2014)... We,ve all waited in line and most of us ... we would like. , For Will Mather, assistant ... of Science,s Integrated Science Curriculum, studying lines, or queues, ... deal with bottlenecks that limit the recycling of proteins. ... an assistant professor, has received attention from the National ...
(Date:4/22/2014)... A new prediction tool can help doctors better identify ... after surgery and therefore prevent the often deadly condition, ... the May issue of Anesthesiology . , Affecting ... (ARDS) is a sudden failure of the lungs caused ... to pneumonia or blood infection. High-risk patients can develop ...
(Date:4/21/2014)... OAK BROOK, Ill. Imaging of the coronary arteries ... of arterial plaque and could have a dramatic impact ... high risk of heart attacks and other cardiovascular events, ... the journal Radiology . , Plaque that forms ... in some cases, rupture, leading to potentially fatal heart ...
Breaking Medicine News(10 mins):Health News:Brain size matters when it comes to animal self-control 2Health News:Brain size matters when it comes to animal self-control 3Health News:$8 million NIH grant will fund multicenter clinical trial of stroke intervention drug 2Health News:$8 million NIH grant will fund multicenter clinical trial of stroke intervention drug 3Health News:Queuing theory helps physicist understand protein recycling 2Health News:New tool helps doctors better predict, prevent deadly respiratory failure 2Health News:CT measures potentially dangerous arterial plaque in diabetic patients 2Health News:CT measures potentially dangerous arterial plaque in diabetic patients 3
... could boost sensitivity, amount of information offered by the ... could some day be injected into the body to ... amount of information provided by the images, according to ... act as "smart tags" that identify specific cells, tissues, ...
... of Survivor Cafe Continues Longstanding ... Community Support By Binson,s, DETROIT, June 18 The fight ... Komen Detroit Race for,the Cure(R) with the participation of 344 participants from ... the Komen Race for the Cure Series has been a celebration,of life, ...
... research awards to states in 2007 created more than ... from those new jobs, and,spurred more than $50 billion ... for NIH Threatens New Health Research, U.S.,Medical Leadership, and ... Institutes,of Health has a legacy of great medical accomplishments, ...
... VW Bus For Fundraising Contest, HERNDON, Va., June ... their hands on legendary rock band The Who,s Magic,Bus ... 1965, signed by Roger,Daltrey and Pete Townshend and specially ... target logo. The competition, in aid of Daltrey,s,charity Teenage ...
... June 21, 2008, New Alternatives,for Children (NAC), a New ... disabilities and/or chronic illnesses, will,hold its 3rd Annual NAC ... 12:00 noon to 3:30 pm rain or shine., ... family members,are expected to participate in the 2008 NAC ...
... June 18 After 25 years, 26 chapters,and more ... the brink of a new era. And, beginning in ... alike can read the latest news,and cutting-edge technologies with ... available, in its entirety, online, offering readers,more opportunities to ...
Cached Medicine News:Health News:'Micromagnets' May One Day Enhance MRI Technology 2Health News:Fight Against Breast Cancer Receives Big Boost During Susan G. Komen Detroit Race for the Cure(R) With 344 Participants From Binson's, Northwood 2Health News:Fight Against Breast Cancer Receives Big Boost During Susan G. Komen Detroit Race for the Cure(R) With 344 Participants From Binson's, Northwood 3Health News:Fight Against Breast Cancer Receives Big Boost During Susan G. Komen Detroit Race for the Cure(R) With 344 Participants From Binson's, Northwood 4Health News:Report: NIH and Global Health Research are a Major Boon to All State Economies 2Health News:Report: NIH and Global Health Research are a Major Boon to All State Economies 3Health News:Volkswagen Partners With Legendary Rock Band 'The Who' To Raise Money for Teenage Cancer Trust Charity 2Health News:Volkswagen Partners With Legendary Rock Band 'The Who' To Raise Money for Teenage Cancer Trust Charity 3Health News:2008 NAC Kids Olympics Celebrates the Achievements and Persevering Spirits of Hundreds of Children with Disabilities and Chronic Illnesses on Saturday, June 21, 2008 at Riverbank State Park 2Health News:2008 NAC Kids Olympics Celebrates the Achievements and Persevering Spirits of Hundreds of Children with Disabilities and Chronic Illnesses on Saturday, June 21, 2008 at Riverbank State Park 3Health News:Dermatology Nurses' Association Teams with International Publisher to Launch its Own Journal 2Health News:Dermatology Nurses' Association Teams with International Publisher to Launch its Own Journal 3
... The Foundation® PS knee offers a femoral option ... cam action that engages at 60 degrees of ... motion and allow for 130 degrees of flexion. ... design with prominent lateral flare. The constrained tibial ...
... System is designed to provide the surgeon ... clinical indications. Based on the clinically successful ... P.F.C. SIGMA continues a history of innovation ... to address implant longevity by maximizing femoro-tibial ...
... Knee System's curved-on-curved articulation maintains full inter-changeability. ... for better patient fit. The Maxim ... knee's proven concepts with expanded options to ... Maxim is indicated for use in total ...
... laser combines excellent cutting, ablation and ... procedures. It is also extremely effective ... stones of all compositions, making it ... its laser light is transmitted through ...
Medicine Products: